Previous 10 | Next 10 |
LEXINGTON, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the publication of a new study highlighting the clinical benefits...
2024-03-12 10:03:27 ET More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Call Transcript T2 Biosystems says it achieved full year 2023 total revenue of $7.2M T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands Seeking Alpha ...
LEXINGTON, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Nasdaq Hearings Panel has granted the Company's request for continued listin...
2024-02-16 10:00:07 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Communication Services, Info ...
2024-02-15 19:37:10 ET T2 Biosystems, Inc. (TTOO) Q4 2023 Earnings Conference Call February 15, 2024, 04:30 PM ET Company Participants Trip Taylor - IR John Sperzel - Chairman & CEO John Sprague - John Sprague Conference Call Participants Ben Hayn...
2024-02-15 16:12:27 ET More on T2 Biosystems T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands Seeking Alpha’s Quant Rating on T2 Biosystems Historical earnings data for T2 Biosystems Financial information for T2 Biosystems R...
2024-02-15 16:10:32 ET More on T2 Biosystems T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands Seeking Alpha’s Quant Rating on T2 Biosystems Historical earnings data for T2 Biosystems Financial information for T2 Biosystems R...
2024-02-15 16:09:25 ET More on T2 Biosystems T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands Seeking Alpha’s Quant Rating on T2 Biosystems Historical earnings data for T2 Biosystems Financial information for T2 Biosystems R...
LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial and operational results for ...
LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the entrance into a definitive agreement to convert $15 million of its term loan with entities a...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it received written notice from the Nasdaq Stock Market LLC (ȁ...
2024-05-17 18:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LEXINGTON, Mass., May 17, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has closed its previously announced private placement for the purchase and sale of an aggregat...